SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
88 hedge funds and large institutions have $98.7M invested in scPharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 33 increasing their positions, 26 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
88
Holders Change
+3
Holders Change %
+3.53%
% of All Funds
1.19%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
12
Increased
33
Reduced
26
Closed
8
Calls
$400K
Puts
$13K
Net Calls
+$387K
Net Calls Change
-$149K
Top Buyers
Top Sellers
1 |
SCM
Suvretta Capital Management
New York
|
-$6.52M |
2 |
UBS Group
Zurich,
Switzerland
|
-$1.87M |
3 |
JGC
J. Goldman & Co
New York
|
-$1.66M |
4 |
WP
Woodline Partners
San Francisco,
California
|
-$1.05M |
5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$883K |